Product Name

  • Name

    7-Methyltryptamine

  • EINECS 238-498-9
  • CAS No. 14490-05-2
  • Article Data11
  • CAS DataBase
  • Density 1.126 g/cm3
  • Solubility Soluble in ethanol (5% w/v)
  • Melting Point 123-130 °C
  • Formula C11H14N2
  • Boiling Point 349.2 °C at 760 mmHg
  • Molecular Weight 174.246
  • Flash Point 192 °C
  • Transport Information
  • Appearance Off-white crystalline powder
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 14490-05-2 (7-Methyltryptamine)
  • Hazard Symbols
  • Synonyms Indole,3-(2-aminoethyl)-7-methyl- (6CI,7CI,8CI);7-Methyltryptamine;NSC 91540;
  • PSA 41.81000
  • LogP 2.67780

Synthetic route

(E)-7-methyl-3-(2-nitrovinyl)-1H-indole

(E)-7-methyl-3-(2-nitrovinyl)-1H-indole

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; Inert atmosphere;99%
With lithium aluminium tetrahydride In tetrahydrofuran
2-(7-methyl-1H-indol-3-yl)acetonitrile
858232-97-0

2-(7-methyl-1H-indol-3-yl)acetonitrile

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride
3-(2-amino-ethyl)-7-methyl-indole-2-carboxylic acid
14517-83-0

3-(2-amino-ethyl)-7-methyl-indole-2-carboxylic acid

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
With hydrogenchloride
4-aminobutyrylaldehyde diethylacetal
6346-09-4

4-aminobutyrylaldehyde diethylacetal

2-methylphenylhydrazine
529-27-1

2-methylphenylhydrazine

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
With zinc(II) chloride
7-methyl-1H-indole
933-67-5

7-methyl-1H-indole

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: POCl3
2: AcOH
3: LiAH4 / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 1.5 h / Cooling with ice
1.2: 20 °C / Cooling with ice
1.3: 1 h / 105 °C
2.1: ammonium acetate / Reflux
3.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: diethyl ether / 18 h / 40 °C
2: ammonia / 1,4-dioxane / 20 °C
3: lithium aluminium tetrahydride / tetrahydrofuran / 18 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1.1: trichlorophosphate / 0.25 h / 0 °C / Inert atmosphere
1.2: 3.25 h / 0 - 20 °C / Inert atmosphere
1.3: 0.08 h / Reflux
2.1: ammonium acetate / 1.5 h / Reflux; Inert atmosphere
3.1: lithium aluminium tetrahydride / tetrahydrofuran / 36 h / 0 - 20 °C / Inert atmosphere
View Scheme
7-methyl-1H-indole-3-carbaldehyde
4771-50-0

7-methyl-1H-indole-3-carbaldehyde

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: AcOH
2: LiAH4 / tetrahydrofuran
View Scheme
Multi-step reaction with 2 steps
1: ammonium acetate / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: ammonium acetate / 2 h / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / 36 h / 0 - 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: ammonium acetate / 1.5 h / Reflux; Inert atmosphere
2: lithium aluminium tetrahydride / tetrahydrofuran / 36 h / 0 - 20 °C / Inert atmosphere
View Scheme
8-methyl-2,3,4,9-tetrahydro-β-carbolin-1-one
14490-04-1

8-methyl-2,3,4,9-tetrahydro-β-carbolin-1-one

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq.-ethanolic KOH
2: aqueous HCl
View Scheme
1-methyl-2-nitrobenzene
88-72-2

1-methyl-2-nitrobenzene

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: tetrahydrofuran / 1 h / -40 °C / Inert atmosphere
2.1: trichlorophosphate / 1.5 h / Cooling with ice
2.2: 20 °C / Cooling with ice
2.3: 1 h / 105 °C
3.1: ammonium acetate / Reflux
4.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C / Inert atmosphere
View Scheme
2-(7-methyl-1H-indol-3-yl)-2-oxoacetyl chloride
59022-69-4

2-(7-methyl-1H-indol-3-yl)-2-oxoacetyl chloride

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ammonia / 1,4-dioxane / 20 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 18 h / Reflux
View Scheme
C11H10N2O2

C11H10N2O2

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran for 18h; Reflux;
C11H10N2O2
566200-37-1

C11H10N2O2

7-methyltryptamine
14490-05-2

7-methyltryptamine

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 36h; Inert atmosphere;
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 36h; Inert atmosphere;
7-methyltryptamine
14490-05-2

7-methyltryptamine

3-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester
101385-93-7

3-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester

8-methyl-2,3,4,9-tetrahydrospiro[β-carboline-1,3'-pyrrolidine] dihydrochloride

8-methyl-2,3,4,9-tetrahydrospiro[β-carboline-1,3'-pyrrolidine] dihydrochloride

Conditions
ConditionsYield
Stage #1: 7-methyltryptamine; 3-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester With acetic acid at 100℃; for 4.5h;
Stage #2: With hydrogenchloride In 1,2-dioxacyclohexane at 20℃;
100%
7-methyltryptamine
14490-05-2

7-methyltryptamine

7-(trifluoromethyl)-3,4,5,6-tetrahydro-2H-azepine
1146222-77-6

7-(trifluoromethyl)-3,4,5,6-tetrahydro-2H-azepine

5-(8-methyl-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)pentan-1-amine

5-(8-methyl-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)pentan-1-amine

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 20℃; for 168h; Pictet-Spengler Synthesis;100%
7-methyltryptamine
14490-05-2

7-methyltryptamine

acetic anhydride
108-24-7

acetic anhydride

N-(2-(7-methyl-1H-indol-3-yl)ethyl)acetamide
769186-81-4

N-(2-(7-methyl-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 1h;99%
7-methyltryptamine
14490-05-2

7-methyltryptamine

2-chloro-ethanol
107-07-3

2-chloro-ethanol

C13H18N2O
1135827-90-5

C13H18N2O

Conditions
ConditionsYield
In dimethyl sulfoxide at 80℃; for 5h;99%
7-methyltryptamine
14490-05-2

7-methyltryptamine

hept-3-ynoic acid
59862-93-0

hept-3-ynoic acid

(11bR)-10-methyl-11b-n-propyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1178541-69-9

(11bR)-10-methyl-11b-n-propyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
Stage #1: hept-3-ynoic acid With triphenylphosphine gold (I) chloride; silver trifluoromethanesulfonate In toluene at 20℃; for 1h;
Stage #2: 7-methyltryptamine With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene at 80 - 110℃; for 48h; optical yield given as %ee; enantioselective reaction;
96%
7-methyltryptamine
14490-05-2

7-methyltryptamine

5-phenylfuran-2(3H)-one

5-phenylfuran-2(3H)-one

(11bS)-10-methyl-11b-phenyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1178541-62-2

(11bS)-10-methyl-11b-phenyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene at 110℃; for 41h; optical yield given as %ee; enantioselective reaction;95%
7-methyltryptamine
14490-05-2

7-methyltryptamine

3-methyllevulinic acid
6628-79-1

3-methyllevulinic acid

(1R,11bR)-1,10,11b-trimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1253404-42-0

(1R,11bR)-1,10,11b-trimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene for 48h; Reflux; optical yield given as %ee; enantioselective reaction;95%
7-methyltryptamine
14490-05-2

7-methyltryptamine

benzaldehyde
100-52-7

benzaldehyde

8-methyl-1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline
865681-23-8

8-methyl-1-phenyl-2,3,4,9-tetrahydro-1H-β-carboline

Conditions
ConditionsYield
With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In ethyl acetate at 110℃; for 0.166667h; Microwave irradiation; Sealed tube;95%
but-3-yne-1-sulfonyl chloride

but-3-yne-1-sulfonyl chloride

7-methyltryptamine
14490-05-2

7-methyltryptamine

N-[2-(7-methyl-1H-indol-3-yl)ethyl]but-3-yne-1-sulfonamide
1452838-33-3

N-[2-(7-methyl-1H-indol-3-yl)ethyl]but-3-yne-1-sulfonamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at -78℃; Inert atmosphere;95%
7-methyltryptamine
14490-05-2

7-methyltryptamine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butyl (2-(7-methyl-1H-indol-3-yl)ethyl)carbamate

tert-butyl (2-(7-methyl-1H-indol-3-yl)ethyl)carbamate

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃;95%
7-methyltryptamine
14490-05-2

7-methyltryptamine

(+/-)-3-acetylheptanoic acid
1253404-36-2

(+/-)-3-acetylheptanoic acid

(1R,11bR)-1-butyl-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1253404-40-8

(1R,11bR)-1-butyl-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
With (R)-3,3'-bis-(triphenylsilyl)octahydrobinolphosphoric acid In toluene for 72h; Reflux; optical yield given as %ee; enantioselective reaction;94%
7-methyltryptamine
14490-05-2

7-methyltryptamine

cinnamyl methyl carbonate
85217-69-2, 87802-71-9

cinnamyl methyl carbonate

N-(2-(7-methyl-1H-indol-3-yl)ethyl)-1-phenylprop-2-en-1-amine
1400791-77-6

N-(2-(7-methyl-1H-indol-3-yl)ethyl)-1-phenylprop-2-en-1-amine

Conditions
ConditionsYield
With C48H49IrNO2P(1+)*CF3O3S(1-) In tetrahydrofuran at 50℃; Schlenk technique; Inert atmosphere;94%
5-methyl-2-furanone
591-12-8

5-methyl-2-furanone

7-methyltryptamine
14490-05-2

7-methyltryptamine

(11bR)-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1178541-60-0

(11bR)-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene at 110℃; for 24h; optical yield given as %ee; enantioselective reaction;92%
7-methyltryptamine
14490-05-2

7-methyltryptamine

2-oxocycloheptaneacetic acid
33366-28-8

2-oxocycloheptaneacetic acid

(5aR,15bR)-14-methyl-2,3,4,5,5a,6,10,15-octahydro-9H-cyclohepta[1,8a]indolizino[8,7-b]indol-7(1H)-one
1253404-47-5

(5aR,15bR)-14-methyl-2,3,4,5,5a,6,10,15-octahydro-9H-cyclohepta[1,8a]indolizino[8,7-b]indol-7(1H)-one

Conditions
ConditionsYield
With (R)-3,3'-bis-(triphenylsilyl)octahydrobinolphosphoric acid In toluene for 48h; Reflux; optical yield given as %ee; enantioselective reaction;91%
7-methyltryptamine
14490-05-2

7-methyltryptamine

ethyl 2-(2-oxocyclohexyl)acetate
24731-17-7

ethyl 2-(2-oxocyclohexyl)acetate

(4aR,14bR)-13-methyl-1,2,3,4,4a,5,9,14-octahydro-6H,8H-pyrido[3,4-b:1,2-i']diindol-6-one
1253404-44-2

(4aR,14bR)-13-methyl-1,2,3,4,4a,5,9,14-octahydro-6H,8H-pyrido[3,4-b:1,2-i']diindol-6-one

Conditions
ConditionsYield
With (R)-3,3'-bis-(triphenylsilyl)octahydrobinolphosphoric acid In toluene for 48h; Reflux; optical yield given as %ee; enantioselective reaction;89%
7-methyltryptamine
14490-05-2

7-methyltryptamine

p-bromophenylpropene methyl carbonate
952686-36-1

p-bromophenylpropene methyl carbonate

1-(4-bromophenyl)-N-(2-(7-methyl-1H-indol-3-yl)ethyl)prop-2-en-1-amine
1400791-80-1

1-(4-bromophenyl)-N-(2-(7-methyl-1H-indol-3-yl)ethyl)prop-2-en-1-amine

Conditions
ConditionsYield
With C48H49IrNO2P(1+)*CF3O3S(1-) In tetrahydrofuran at 50℃; Schlenk technique; Inert atmosphere;87%
7-methyltryptamine
14490-05-2

7-methyltryptamine

N-(2-(7-methyl-1H-indol-3-yl)ethyl)-1-(3-(trifluoromethyl)phenyl)prop-2-en-1-amine
1400791-81-2

N-(2-(7-methyl-1H-indol-3-yl)ethyl)-1-(3-(trifluoromethyl)phenyl)prop-2-en-1-amine

Conditions
ConditionsYield
With C48H49IrNO2P(1+)*CF3O3S(1-) In tetrahydrofuran at 50℃; Schlenk technique; Inert atmosphere;86%
7-methyltryptamine
14490-05-2

7-methyltryptamine

N-ethoxycarbonylphthalimide
22509-74-6

N-ethoxycarbonylphthalimide

2-[2-(7-Methyl-1H-indol-3-yl)-ethyl]-isoindole-1,3-dione
192182-62-0

2-[2-(7-Methyl-1H-indol-3-yl)-ethyl]-isoindole-1,3-dione

Conditions
ConditionsYield
In tetrahydrofuran for 48h; Heating;85%
7-methyltryptamine
14490-05-2

7-methyltryptamine

dec-3-ynoic acid
27007-78-9

dec-3-ynoic acid

(11bR)-11b-hexyl-10-methyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1178541-61-1

(11bR)-11b-hexyl-10-methyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
Stage #1: dec-3-ynoic acid With triphenylphosphine gold (I) chloride; silver trifluoromethanesulfonate In toluene at 20℃; for 1h;
Stage #2: 7-methyltryptamine With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene at 80 - 110℃; for 48h; optical yield given as %ee; enantioselective reaction;
84%
7-methyltryptamine
14490-05-2

7-methyltryptamine

acetophenone
98-86-2

acetophenone

(8-methyl-9H-pyrido[3,4-b]indol-1-yl)(phenyl)methanone

(8-methyl-9H-pyrido[3,4-b]indol-1-yl)(phenyl)methanone

Conditions
ConditionsYield
With dihydrogen peroxide; iodine In water; dimethyl sulfoxide at 110℃;84%
1-oxaspiro(2.5)octane
185-70-6

1-oxaspiro(2.5)octane

7-methyltryptamine
14490-05-2

7-methyltryptamine

C18H26N2O
1135827-71-2

C18H26N2O

Conditions
ConditionsYield
In ethanol at 60℃; for 18h;82%
7-methyltryptamine
14490-05-2

7-methyltryptamine

methyl chloroformate
79-22-1

methyl chloroformate

methyl (2-(7-methyl-1H-indol-3-yl)ethyl)carbamate

methyl (2-(7-methyl-1H-indol-3-yl)ethyl)carbamate

Conditions
ConditionsYield
With sodium hydroxide In ethyl acetate at 20℃;82%
With triethylamine In dichloromethane at 0 - 20℃; for 3h; Inert atmosphere;
With sodium hydroxide In water; ethyl acetate at 20℃; for 1h; Inert atmosphere;
With sodium carbonate In dichloromethane; water for 2h; Inert atmosphere;
7-methyltryptamine
14490-05-2

7-methyltryptamine

hexadec-3-ynoic acid
89199-90-6

hexadec-3-ynoic acid

(11bR)-11b-dodecyl-10-methyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1178541-70-2

(11bR)-11b-dodecyl-10-methyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
Stage #1: hexadec-3-ynoic acid With triphenylphosphine gold (I) chloride; silver trifluoromethanesulfonate In toluene at 20℃; for 1h;
Stage #2: 7-methyltryptamine With (R)-3,3'-bis(triphenylsilyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate In toluene at 80 - 110℃; for 48h; optical yield given as %ee; enantioselective reaction;
81%
7-methyltryptamine
14490-05-2

7-methyltryptamine

(+/-)-3-ethyl-4-oxopentanoic acid
4439-86-5

(+/-)-3-ethyl-4-oxopentanoic acid

(1R,11bR)-1-ethyl-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one
1253404-43-1

(1R,11bR)-1-ethyl-10,11b-dimethyl-1,2,5,6,11,11b-hexahydro-3H-indolizino[8,7-b]indol-3-one

Conditions
ConditionsYield
With (R)-3,3'-bis-(triphenylsilyl)octahydrobinolphosphoric acid In toluene for 54h; Reflux; optical yield given as %ee; enantioselective reaction;81%
7-methyltryptamine
14490-05-2

7-methyltryptamine

1-(4-isobutylphenyl)-N-(2-(7-methyl-1H-indol-3-yl)ethyl)prop-2-en-1-amine
1400791-79-8

1-(4-isobutylphenyl)-N-(2-(7-methyl-1H-indol-3-yl)ethyl)prop-2-en-1-amine

Conditions
ConditionsYield
With C48H49IrNO2P(1+)*CF3O3S(1-) In tetrahydrofuran at 50℃; Schlenk technique; Inert atmosphere;78%
methyl crotyl carbonate

methyl crotyl carbonate

7-methyltryptamine
14490-05-2

7-methyltryptamine

N-(2-(7-methyl-1H-indol-3-yl)ethyl)but-3-en-2-amine
1400791-82-3

N-(2-(7-methyl-1H-indol-3-yl)ethyl)but-3-en-2-amine

Conditions
ConditionsYield
With C48H49IrNO2P(1+)*CF3O3S(1-) In tetrahydrofuran at 50℃; Schlenk technique; Inert atmosphere;78%
7-methyltryptamine
14490-05-2

7-methyltryptamine

hept-1-en-3-yl methyl carbonate
1239597-30-8

hept-1-en-3-yl methyl carbonate

N-(2-(7-methyl-1H-indol-3-yl)ethyl)hept-1-en-3-amine
1400791-83-4

N-(2-(7-methyl-1H-indol-3-yl)ethyl)hept-1-en-3-amine

Conditions
ConditionsYield
With C48H49IrNO2P(1+)*CF3O3S(1-) In tetrahydrofuran at 50℃; Schlenk technique; Inert atmosphere;78%
7-methyltryptamine
14490-05-2

7-methyltryptamine

6-(trifluoromethyl)-2,3,4,5-tetrahydropyridine
1146222-76-5

6-(trifluoromethyl)-2,3,4,5-tetrahydropyridine

4-(8-methyl-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)butan-1-amine

4-(8-methyl-1-(trifluoromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)butan-1-amine

Conditions
ConditionsYield
With camphor-10-sulfonic acid In water at 130℃; for 14h; Pictet-Spengler Synthesis;77%
7-methyltryptamine
14490-05-2

7-methyltryptamine

3,6-dibromo-9-(oxiran-2-ylmethyl)-9H-carbazole
85446-05-5

3,6-dibromo-9-(oxiran-2-ylmethyl)-9H-carbazole

1-(3,6-dibromo-9H-carbazol-9-yl)-3-((2-(7-methyl-1H-indol-3-yl)ethyl)amino)propan-2-ol

1-(3,6-dibromo-9H-carbazol-9-yl)-3-((2-(7-methyl-1H-indol-3-yl)ethyl)amino)propan-2-ol

Conditions
ConditionsYield
In ethanol for 12h; Inert atmosphere; Reflux;77%

7-Methyltryptamine Specification

The 7-Methyltryptamine, with the cas registry number 14490-05-2 and EINECS registry number 238-498-9, has the systematic name of 2-(7-methyl-1H-indol-3-yl)ethanamine. The molecular formula of the chemical is C11H14N2. The chemical belongs to the following product categories: Tryptamines; Heterocyclic Compounds; Building Blocks; Heterocyclic Building Blocks; Indoles. What's meore, it should be stored at the temperature of -20°C.

The characteristics of this chemical are as followings: (1)ACD/LogP: 1.84; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.25; (4)ACD/LogD (pH 7.4): -0.77; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 2; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 3; (12)Polar Surface Area: 8.17 Å2; (13)Index of Refraction: 1.65; (14)Molar Refractivity: 56.43 cm3; (15)Molar Volume: 154.6 cm3; (16)Polarizability: 22.37×10-24cm3; (17)Surface Tension: 51.3 dyne/cm; (18)Density: 1.126 g/cm3; (19)Flash Point: 192 °C; (20)Enthalpy of Vaporization: 59.37 kJ/mol; (21)Boiling Point: 349.2 °C at 760 mmHg; (22)Vapour Pressure: 4.77E-05 mmHg at 25°C.

Addtionally, the following datas could be converted into the molecular structure:
(1)SMILES: c1ccc(c2c1c(cn2)CCN)C
(2)InChI: InChI=1/C11H14N2/c1-8-3-2-4-10-9(5-6-12)7-13-11(8)10/h2-4,7,13H,5-6,12H2,1H3
(3)InChIKey: SGGBZKQTWMKXHD-UHFFFAOYAH

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 63mg/kg (63mg/kg)   U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#12400,

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View